Error: Could not add to watchlist. X
+ Watchlist

Halozyme Therapeutics Inc

HALO:US
NASDAQ GS
9.94
USD
0.17
1.74%
As of 8:10 PM EDT 7/29/2016
Open
9.70
Day Range
9.50 - 9.97
Volume
1,074,217
Previous Close
9.77
52Wk Range
6.96 - 25.00
1 Yr Return
-57.41%
Open
9.70
Day Range
9.50 - 9.97
Volume
1,074,217
Previous Close
9.77
52Wk Range
6.96 - 25.00
1 Yr Return
-57.41%
YTD Return
-42.64%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.30
Market Cap (b USD)
1.284
Shares Outstanding (m)
129.140
Price/Sales (TTM)
7.94
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology, and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
Address
11388 Sorrento Valley Road
San Diego, CA 92121
United States
Phone
1-858-794-8889
Show More